Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

DR. BRYAN ARDIS | HOW COVID-19 HOSPITAL PROTOCOLS ARE LITERALLY KILLING PEOPLE INCLUDING HIS OWN FATHER-IN-LAW

CDC website directs patients and doctors to NIH Website for a protocol for treating COVID Patients.

https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.

scroll down to “clinical management and treatment” and also “severe disease”, will be click link directing you to NIH guidelines.
NIH issues Protocol to Hospitals, how to treat COVID patients.

https://www.covid19treatmentguidelines.nih.gov/whats-new/.

Read Remdesivir protocol on NIH site Remdesivir is an INVESTIGATIONAL DRUG and is NOT FDA APPROVED FOR ANYTHING.

Do you know what the side effects of this NIH recommended investigational drug, which is also confirmed to NOT be FDA approved yet.

https://www.drugs.com/sfx/remdesivir-side-effects.html
read the 3 summaries under the warning section, 3 chinese produced findings from clinical experiences in CHINA on COVID patients.

I quote:

A cohort of 53 hospitalized patients in manufacturer’s compassionate-use program: Adverse effects (e.g., increased hepatic enzymes, diarrhea, rash, renal impairment, hypotension) reported in 60% of patients; serious adverse effects (e.g., multiple organ dysfunction syndromes, septic shock, acute kidney injury, hypotension) reported in 23%; drug discontinued because of adverse effects in 8% of patients.

https://www.thrivetimeshow.com/business-podcasts/dr-bryan-ardis-how-covid-19-hospital-protocols-are-literally-killing-people-including-his-own-father-in-law/.

WHO IS ASKING FOR SPECIAL TREATMENT, BILLIONAIRES???

You can’t sue Pfizer or Moderna if you have severe Covid vaccine side effects. The government likely won't compensate you for damages either

https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-compensation-lawsuit.html

FDA, ARE YOU GIVING AVIPTADIL EUA AND APPROVAL,...YESTERDAY???

Leukocyte trafficking is fundamental for immune responses and inflammation, as well as for the development of secondary immune tissues. Chemokines are key mediators of leukocyte chemotaxis to inflammatory sites in ailments including infectious diseases (1), asthma (2), rheumatoid arthritis (3), and inflammatory bowel disease (4, 5), and diseases hitherto thought noninflammatory, such as atherosclerosis (6).The key role of chemokines and their receptors in disease is highlighted by their subversion by pathogens such as herpesviruses, poxviruses, and HIV (7). Factors that mitigate chemokine functions are therefore desirable as therapeutic agents. Gene deletion animals and inhibition studies of specific chemokine receptors, however, suggest significant overlap in function. Thus, novel therapeutic strategies are required to target a number of receptors simultaneously to abrogate leukocyte recruitment and activation pathways.

https://www.jimmunol.org/content/171/10/4990

AND RAM, HAVE YOU PAID THE $4 MILLION TO NEURO RX OR DO YOU CARE AT ALL ABOUT THE USA THERAPEUTICS MARKET??? WHY MAKE BILLIONS WHEN WE CAN MAKE, MILLIONS???

https://www.marketdataforecast.com/market-reports/north-america-cancer-immunotherapy-market